Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B. | Int J Mol Sci | 2023 | 36834542 | PubTator, text mining | PubMed |
| CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement. | Cancers (Basel) | 2023 | 36831591 | PubTator, text mining | PubMed |
| CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging Targets. | Cancers (Basel) | 2023 | 36831514 | PubTator, text mining | PubMed |
| CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy. | Cancers (Basel) | 2023 | 36831396 | PubTator, text mining | PubMed |
| Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center Input. | Cancers (Basel) | 2023 | 36831349 | PubTator, text mining | PubMed |
| Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies. | Biomedicines | 2023 | 36831164 | PubTator, text mining | PubMed |
| CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target Antigens. | Biology (Basel) | 2023 | 36829563 | PubTator, text mining | PubMed |
| Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering. | Cytotherapy | 2023 | 36828738 | PubTator, text mining | PubMed |
| Labeling T Cells to Track Immune Response to Immunotherapy in Glioblastoma. | Tomography | 2023 | 36828374 | PubTator, text mining | PubMed |
| Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. | Curr Oncol | 2023 | 36826113 | PubTator, text mining | PubMed |
| A stay of execution: ATF4 regulation and potential outcomes for the integrated stress response. | Front Mol Neurosci | 2023 | 36825279 | PubTator, text mining | PubMed |
| The biological role and immunotherapy of gangliosides and GD3 synthase in cancers. | Front Cell Dev Biol | 2023 | 36824365 | PubTator, text mining | PubMed |
| Mapping the interplay between NK cells and HIV: therapeutic implications. | J Leukoc Biol | 2023 | 36822173 | PubTator, text mining | PubMed |
| Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma. | Blood | 2023 | 36821767 | PubTator, text mining | PubMed |
| Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. | Mol Ther Oncolytics | 2023 | 36816749 | PubTator, text mining | PubMed |
| CAR immune cells: design principles, resistance and the next generation. | Nature | 2023 | 36813894 | PubTator, text mining | PubMed |
| T cells engineered with full-length NKG2D linked to signaling domains of 4-1BB and CD3ζ show enhanced antitumor activity. | Immunol Cell Biol | 2023 | 36811384 | PubTator, text mining | PubMed |
| Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment. | Mol Cancer | 2023 | 36810098 | PubTator, text mining | PubMed |
| A Novel Cell-based Luciferase Reporter Platform for the Development and Characterization of T-Cell Redirecting Therapies and Vaccine Development. | J Immunother | 2023 | 36809225 | PubTator, text mining | PubMed |
| Convection-enhanced delivery of nanoencapsulated gene locoregionally yielding ErbB2/Her2-specific CAR-macrophages for brainstem glioma immunotherapy. | J Nanobiotechnology | 2023 | 36805678 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=39